Re-Psychopathologization Campaign

Restoring Clinical Clarity on Gender Distress

Read our policy statement calling for the restoration of psychiatric safeguards in the treatment of gender-related distress through the re-psychopathologization of the drive to medically transition.

📄

Policy Statement

Restoring Clinical Clarity on Gender Distress

Stella O’Malley; Amanda Miller; Mia Hughes | October 2025

This policy statement calls for restoring psychiatric safeguards in the treatment of gender-related distress through re-psychopathologization of the drive to medically transition. Using the clinical construct of the extreme overvalued belief, it identifies the obsessive pursuit of irreversible body modification as a pathological fixation rather than an innate identity.

WPATH’s de-psychopathologization campaign was politically motivated, removing essential mental health protections and enabling medical overreach. Evidence of poor long-term outcomes and rising harm supports the need to re-establish psychiatric frameworks, end affirmation-only protocols, and protect minors and vulnerable adults.

Key Sections:

  • The Problem: Clinical thresholds and WPATH’s de-psychopathologization campaign
  • The Evidence: Clinical framework, outcome data, and documented harm
  • Re-Psychopathologization: Requirements, rationale, and clinical guidelines
  • Call to Action: Specific policy recommendations for governments and medical bodies

The Depsychopathologization Campaign Timeline

Genspect’s repathologization campaign arose in response to WPATH’s depsychopathologization campaign, which reframed a clinical phenomenon in ways that departed from established principles of mental health care.

1992 ICTLEP begins
2007 HBIGDA → WPATH
2010 WPATH Statement
2018 WHO ICD-11
2025 Genspect responds

Explore the full documented history of the political and advocacy-driven shift that removed clinical safeguards.

View Complete Timeline →

Why Re-Psychopathologization?

The 2010 declaration by the World Professional Association for Transgender Health to “de-psychopathologize” gender variance was not based on scientific discovery but on political advocacy. This campaign has caused catastrophic harm by removing essential psychiatric guardrails, fueling a social contagion, and exposing vulnerable people to experimental medicalization.

Re-psychopathologization is not a call to re-stigmatize or marginalize individuals who identify as transgender. It is a call to restore compassion and clarity: to understand that this condition is pathological, not innate; to treat it as an all-consuming fixation requiring careful, appropriate, ethical psychological intervention, and to prevent the unchecked spread of this harmful belief.

Only by returning to this clinical understanding of transgender identities can we protect children, adolescents, and vulnerable adults and offer genuine help to all those consumed by this belief.

Key Resources

Evidence & Research

WPATH De-Psychopathologization Campaign (2010-2018)

+

2010: WPATH De-Psychopathologization Statement

On May 26, 2010, WPATH’s Board of Directors released their landmark statement declaring: “The expression of gender characteristics, including identities, that are not stereotypically associated with one’s assigned sex at birth is a common and culturally-diverse human phenomenon which should not be judged as inherently pathological or negative.” This political statement, not based on scientific discovery, launched the de-psychopathologization movement that removed essential psychiatric guardrails.

WPATH Public Statements Page →

2013: DSM-5 Diagnostic Change

The American Psychiatric Association replaced “Gender Identity Disorder” with “Gender Dysphoria,” shifting focus from the identity to the distress. The DSM-5 explicitly stated: “gender non-conformity is not in itself a mental disorder.” This change reflected WPATH’s advocacy rather than new scientific evidence.

APA Gender Dysphoria Diagnosis → DSM-5 Gender Dysphoria Fact Sheet (PDF) → Psychiatric News: “New Gender Dysphoria Criteria Replace GID” (2013) →

2018: ICD-11 Goes Even Further

The World Health Organization removed transgender-related diagnoses from mental health disorders entirely, creating “Gender Incongruence” in a new chapter called “Conditions Related to Sexual Health.” Unlike DSM-5, the ICD-11 explicitly states gender incongruence is NOT a mental disorder—completing WPATH’s de-psychopathologization campaign.

WHO Gender Incongruence FAQ → UN News: “UN health agency drops ‘gender identity disorder'” (May 2019) → UN Human Rights Statement (2019) →

Extreme Overvalued Beliefs: The Psychiatric Concept

+

Carl Wernicke’s “Overvalued Ideas” (1892)

German neuropsychiatrist Carl Wernicke first described “überwertige Idee” (overvalued idea) in 1892—beliefs that influence behavior to a pathological degree but are shared by others in a culture, distinguishing them from delusions. These beliefs are ego-syntonic (accepted by the person as their own) and can dominate thinking to the point of driving destructive behavior.

Journal of the American Academy of Psychiatry and the Law (2019): “Extreme Overvalued Belief and the Legacy of Carl Wernicke” – Rahman, Meloy & Bauer → PMC (2018): “Extreme Overvalued Beliefs: How Violent Extremist Beliefs Become ‘Normalized'” →

Validation of “Extreme Overvalued Beliefs” (2020)

This landmark study by Rahman and colleagues validated the concept of extreme overvalued beliefs as separate from both delusions and obsessions. The research demonstrates strong inter-rater reliability (kappa = 0.91) among forensic psychiatrists in identifying these pathological fixations, which are shared with a subculture, grow more dominant over time, and may drive individuals to carry out harmful acts.

Journal of the American Academy of Psychiatry and the Law (2020): “Extreme Overvalued Beliefs” – Rahman et al. →

Dr. Tahir Rahman’s Book on Extreme Overvalued Beliefs

Dr. Tahir Rahman, forensic psychiatrist and FBI consultant, has revived Wernicke’s concept in modern threat assessment contexts. His comprehensive text examines how extreme overvalued beliefs manifest in mass shootings, terrorism, and targeted violence—providing crucial clinical and forensic frameworks applicable to understanding gender dysphoria as a socially-reinforced pathological fixation.

Rahman, T., & Abugel, J. (2024). Extreme Overvalued Beliefs: Clinical and Forensic Psychiatric Dimensions. Oxford University Press.

Learn more →

Paul McHugh’s Research on Overvalued Ideas & Social Contagion

+

Multiple Personality Disorder as Social Artifact

Dr. Paul McHugh (Chief of Psychiatry at Johns Hopkins, 1975-2001) demonstrated how Multiple Personality Disorder was an “individually and socially created artifact”—a false belief system reinforced by therapists and popular culture that led to iatrogenic harm. His analysis provides a crucial precedent for understanding how psychiatric conditions can be socially constructed and spread through cultural reinforcement, directly paralleling the current transgender identification epidemic.

PubMed: “Multiple Personality Disorder is an Individually and Socially Created Artifact” (Canadian Journal of Psychiatry, 1995) →

“Try to Remember”: The Recovered Memory Movement

McHugh’s book analyzes how false beliefs about “recovered memories” of childhood abuse took hold in psychiatry and caused devastating harm. His examination of how overvalued ideas can capture entire professional fields and create iatrogenic epidemics offers essential insights for understanding the gender medicine crisis. The parallels are striking: both movements rejected skepticism, pathologized doubt, and prioritized “affirming” false beliefs over careful clinical assessment.

McHugh, P.R. (2008). Try to Remember: Psychiatry’s Clash over Meaning, Memory, and Mind. Dana Press.

Learn more →

Johns Hopkins Gender Identity Clinic Closure (1979)

Recent archival research reveals McHugh arrived at Johns Hopkins in 1975 “with the intent of ending the Gender Identity Clinic” based on concerns about the evidence base and outcomes. The 1979 closure followed the Meyer-Reter study which found no psychological benefit from sex reassignment surgery. This history demonstrates that questions about transition as treatment existed from the beginning—and were suppressed by advocacy rather than answered by science.

Annals of Internal Medicine (2022): “The Fall of the Nation’s First Gender-Affirming Surgery Clinic” → STAT News (2022): “‘History is repeating itself'” → Meyer-Reter Study (1979) – Used to justify clinic closure →

WPATH History & Standards of Care Evolution

+

Reed Erickson Educational Foundation (1960s-70s)

Reed Erickson (1917-1992), a trans-identified female, funded virtually all early transgender research and medical care in the 1960s-70s, including the Johns Hopkins Gender Identity Clinic and the first HBIGDA (now WPATH) symposia. This reveals how transgender medicine was built not on objective science, but on activist funding with a predetermined agenda to normalize and expand access to transition.

WPATH Official History →

HBIGDA to WPATH Name Change (2006-2007)

The organization changed from Harry Benjamin International Gender Dysphoria Association to World Professional Association for Transgender Health to eliminate the term “gender dysphoria” and emphasize “health” over “illness.” This was a deliberate political rebranding, not a scientific development—laying groundwork for the 2010 de-psychopathologization statement.

WPATH History Page →

Standards of Care Version 7 (2012)

The first SOC to formally incorporate de-psychopathologization principles following WPATH’s 2010 statement. This version removed many safeguards, stating “Psychotherapy is not an absolute requirement for hormone therapy and surgery” and shifted toward an “informed consent” model that prioritized patient demands over clinical judgment.

Published Version (International Journal of Transgenderism, 2012) →

Standards of Care Version 8 (2022)

Current version, over 250 pages, continuing and expanding the de-psychopathologization approach with minimal evidence requirements. SOC-8 explicitly endorses “gender-affirming” care while contradicting itself by also acknowledging the lack of quality evidence—revealing WPATH’s prioritization of ideology over scientific rigor.

WPATH Standards of Care Version 8 →

John Money & the Origins of Gender Identity Theory

+

John Money (1921-2006)

John Money co-founded the Johns Hopkins Gender Identity Clinic in 1965 with Claude Migeon, funded by Reed Erickson. Money invented the concept of “gender identity” as distinct from biological sex and promoted the theory that gender is socially constructed and malleable. His theories shaped early gender medicine despite lacking scientific validation.

Key Publication: Green, R., & Money, J. (Eds.). (1969). Transsexualism and Sex Reassignment. Johns Hopkins University Press.

The David Reimer Case: Money’s Theory Put to the Test

John Colapinto’s investigation of the David Reimer case reveals the devastating consequences of Money’s gender theory in practice. Money claimed he had successfully “reassigned” David Reimer’s gender after a botched circumcision, presenting the case as proof that gender identity is malleable. In reality, Reimer never accepted his imposed female identity, detransitioned as a teenager, and tragically died by suicide. This case demonstrates the fundamental falseness of “gender identity” theory—yet Money’s ideas continue to dominate gender medicine.

Colapinto, J. (2000). As Nature Made Him: The Boy Who Was Raised as a Girl. HarperCollins.

Learn more →

“The Man Who Invented Gender”

Terry Goldie’s academic examination of John Money’s ideas and their lasting influence on transgender medicine and theory. This book provides essential context for understanding how current gender ideology rests on the pseudoscientific foundations laid by Money.

Goldie, T. (2014). The Man Who Invented Gender: Engaging the Ideas of John Money. UBC Press.

Learn more →

Key Researchers: Blanchard, Littman & Contemporary Work

+

Ray Blanchard’s Autogynephilia Research

Dr. Ray Blanchard developed the two-type taxonomy of male-to-female transsexualism at Toronto’s Clarke Institute (1980-1995). His research identified autogynephilia—a male’s sexual arousal to the thought or image of himself as female—as a key driver in many cases of gender dysphoria in males. Blanchard’s work reveals that for many males, transgender identification is rooted in a paraphilic sexual interest, not an innate identity. This research has been systematically suppressed by trans activists who recognize its implications.

PubMed: “The Concept of Autogynephilia and the Typology of Male Gender Dysphoria” (Journal of Nervous and Mental Disease, 1989) → Quillette Interview: “What is Autogynephilia?” (2019) →

Lisa Littman’s Rapid Onset Gender Dysphoria Study (2018)

Dr. Lisa Littman’s study documented a pattern of sudden-onset gender dysphoria in adolescents and young adults, often following immersion in online transgender communities and clustering within peer groups. Her research provided the first systematic evidence of social contagion in gender dysphoria—demonstrating that transgender identification can spread through social influence rather than emerging from an innate condition. The study faced intense backlash and demands for retraction from trans activists, revealing the field’s hostility to research challenging affirmative care.

PLOS ONE (2019, corrected): “Parent Reports of Adolescents and Young Adults Perceived to Show Signs of a Rapid Onset of Gender Dysphoria” →

GATE (Global Action for Trans Equality)

International transgender activist organization that played a documented role in lobbying the WHO to depathologize transgender identities in ICD-11. GATE’s successful advocacy campaign demonstrates how activist organizations, not scientific evidence, drove the removal of gender incongruence from mental health diagnoses.

GATE Official Website → GATE About Us →

Join the Conversation

We welcome constructive feedback and dialogue. If you have questions, concerns, or suggestions about the re-psychopathologization campaign, please reach out to us.

Media Contact: media@genspect.org
General Inquiries: info@genspect.org